NF-KB Pathway Inhibitors
Learn MoreFatty acid synthase (FAS) inhibitors are a class of compounds that target the FAS enzyme which plays a crucial role in the synthesis of fatty acids As its name suggests FAS inhibitors are designed to inhibit the activity of this enzyme thus impeding the production of fatty acids This is especially relevant in the context of diseases such as cancer as cancer cells typically have high levels of FAS activity to support their rapid growth By blocking FAS FAS inhibitors offer a potential therapeutic strategy for inhibiting tumor growth and progression Our company specializes in providing a range of advanced FAS inhibitors offering researchers and clinicians valuable tools for studying and potentially treating FAS-dependent diseases
Catalog Number | Chemical Name | CAS # | Price |
---|---|---|---|
BC-0835 | Cerulenin | 17397-89-6 | Online Inquiry |
EI-0767 | DPVP | 223386-36-5 | Online Inquiry |
EI-0968 | FAS Inhibitor, C75 | 191282-48-1 | Online Inquiry |
EI-1097 | GSK-2194069 | 1332331-21-1 | Online Inquiry |
EI-1291 | KR-33493 | 1021497-97-1 | Online Inquiry |
EI-2224 | TVB-2640 | 1399177-37-7 | Online Inquiry |
EI-2359 | α-Mangostin | 6147-11-1 | Online Inquiry |
Fatty Acid Synthase (FAS) Inhibitors offer numerous applications in the field of cancer research and treatment By targeting the activity of FAS these inhibitors can effectively disrupt the synthesis of fatty acids which are essential for the growth and proliferation of cancer cells Inhibiting FAS can halt cancer cell growth and potentially lead to the development of novel anti-cancer therapies
Furthermore FAS inhibitors can also be utilized in metabolic research to explore the role of fatty acid synthesis in various biological processes By modulating FAS activity scientists can gain a deeper understanding of how fatty acids contribute to cellular functions metabolic disorders and other diseases
In the pharmaceutical industry FAS inhibitors hold promise for the development of anti-obesity drugs By inhibiting the synthesis of fatty acids these inhibitors can help regulate lipid metabolism and potentially reduce the accumulation of fat in the body Such drugs could be valuable tools for combating obesity and related health conditions
Overall Fatty Acid Synthase (FAS) Inhibitors offer a wide range of applications in cancer research metabolic studies and the development of novel therapeutics for cancer metabolic disorders and obesity
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.